nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—focal segmental glomerulosclerosis	0.901	1	CbGaD
Bismuth Subsalicylate—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.0077	0.0867	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.00659	0.0742	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.00628	0.0707	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00456	0.0513	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00362	0.0407	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.00307	0.0346	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00292	0.0329	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.00239	0.0269	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.00181	0.0204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.00158	0.0178	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.00157	0.0177	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00153	0.0172	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00151	0.017	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.0015	0.0169	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00141	0.0159	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.0014	0.0158	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.00131	0.0147	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—focal segmental glomerulosclerosis	0.00131	0.0147	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.0013	0.0146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00127	0.0143	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.00125	0.014	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	0.00124	0.014	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—focal segmental glomerulosclerosis	0.00124	0.014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.0012	0.0135	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00117	0.0132	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.00114	0.0129	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00112	0.0126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—nephron—focal segmental glomerulosclerosis	0.00108	0.331	CbGeAlD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.00103	0.0116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00101	0.0114	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00101	0.0114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000864	0.00973	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000839	0.00945	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.000825	0.0093	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000794	0.00894	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.000786	0.00886	CbGpPWpGaD
Bismuth Subsalicylate—TF—kidney—focal segmental glomerulosclerosis	0.000726	0.222	CbGeAlD
Bismuth Subsalicylate—TF—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000723	0.00814	CbGpPWpGaD
Bismuth Subsalicylate—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.0992	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000697	0.00785	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000697	0.00785	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000677	0.00763	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000664	0.00748	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000626	0.00705	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000621	0.007	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000604	0.0068	CbGpPWpGaD
Bismuth Subsalicylate—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.083	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00058	0.00653	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000579	0.00652	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—endothelium—focal segmental glomerulosclerosis	0.000535	0.163	CbGeAlD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000532	0.006	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000528	0.00594	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—endothelium—focal segmental glomerulosclerosis	0.000511	0.156	CbGeAlD
Bismuth Subsalicylate—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.0712	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000433	0.0606	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00041	0.00462	CbGpPWpGaD
Bismuth Subsalicylate—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000377	0.0527	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000366	0.00412	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000359	0.00405	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000355	0.004	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000344	0.00387	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000343	0.00386	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000342	0.00385	CbGpPWpGaD
Bismuth Subsalicylate—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0468	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000305	0.0427	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000299	0.00337	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000298	0.00336	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000286	0.00322	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000278	0.00313	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000274	0.00309	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000273	0.0382	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000273	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000272	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000258	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000256	0.00289	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000255	0.00288	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.0347	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000238	0.00268	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.0329	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000227	0.00256	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000221	0.00249	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000217	0.0304	CcSEcCtD
Bismuth Subsalicylate—PTGS1—kidney—focal segmental glomerulosclerosis	0.000215	0.0657	CbGeAlD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000214	0.0024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000207	0.00234	CbGpPWpGaD
Bismuth Subsalicylate—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.029	CcSEcCtD
Bismuth Subsalicylate—PTGS2—kidney—focal segmental glomerulosclerosis	0.000206	0.0628	CbGeAlD
Bismuth Subsalicylate—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.027	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000192	0.00217	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000189	0.00213	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000184	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.0247	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000169	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000165	0.00186	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000153	0.00172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.00015	0.00169	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.0207	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.0206	CcSEcCtD
Bismuth Subsalicylate—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.0204	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.000143	0.00161	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.0196	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000136	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000134	0.00151	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000132	0.00148	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000131	0.0183	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000129	0.0181	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000128	0.0179	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000127	0.00143	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.0176	CcSEcCtD
Bismuth Subsalicylate—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.0176	CcSEcCtD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000124	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.017	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000117	0.00132	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.0163	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0163	CcSEcCtD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000114	0.00128	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00011	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000109	0.00122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000104	0.0146	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.0141	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.0001	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	9.72e-05	0.0136	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	9.35e-05	0.0131	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.32e-05	0.00105	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Cyclosporine—focal segmental glomerulosclerosis	9.27e-05	0.013	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.27e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	9.26e-05	0.013	CcSEcCtD
Bismuth Subsalicylate—Headache—Cyclosporine—focal segmental glomerulosclerosis	9.21e-05	0.0129	CcSEcCtD
Bismuth Subsalicylate—Nausea—Cyclosporine—focal segmental glomerulosclerosis	8.73e-05	0.0122	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.57e-05	0.000965	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.97e-05	0.000898	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.71e-05	0.000868	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.54e-05	0.000849	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.54e-05	0.000849	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.95e-05	0.000782	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	6.8e-05	0.000766	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.67e-05	0.000751	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	6.55e-05	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.47e-05	0.000728	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.45e-05	0.000726	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.12e-05	0.000689	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	5.99e-05	0.000674	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.52e-05	0.000621	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	5.5e-05	0.00062	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.45e-05	0.000613	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	5.23e-05	0.000589	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	4.96e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	4.84e-05	0.000545	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	4.47e-05	0.000504	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.46e-05	0.000503	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	4.15e-05	0.000467	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	3.87e-05	0.000436	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	3.55e-05	0.0004	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.44e-05	0.000387	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	3.43e-05	0.000386	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	3.36e-05	0.000378	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	3.26e-05	0.000367	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	2.87e-05	0.000323	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	2.72e-05	0.000307	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	2.06e-05	0.000232	CbGpPWpGaD
